Form	Accession ID	Report Date	Filing Date	Accepted At	Source
10-Q	0001493152-26-036619	Jun 30, 2026	Aug 7, 2026	Aug 7, 2026 20:45 UTC	EDGAR
8-K	0001493152-26-036486	Aug 7, 2026	Aug 7, 2026	Aug 7, 2026 12:30 UTC	EDGAR
8-K	0001493152-26-035672	Jul 30, 2026	Jul 31, 2026	Jul 31, 2026 21:15 UTC	EDGAR
8-K	0001493152-26-034711	Jul 27, 2026	Jul 27, 2026	Jul 27, 2026 12:30 UTC	EDGAR
8-K	0001493152-26-034183	Jul 22, 2026	Jul 22, 2026	Jul 22, 2026 12:30 UTC	EDGAR
8-K	0001493152-26-032263	Jul 7, 2026	Jul 7, 2026	Jul 7, 2026 12:54 UTC	EDGAR
8-K	0001493152-26-031327	Jun 30, 2026	Jun 30, 2026	Jun 30, 2026 21:19 UTC	EDGAR
8-K	0001493152-26-029384	Jun 16, 2026	Jun 18, 2026	Jun 18, 2026 21:07 UTC	EDGAR

Direct links to SEC EDGAR. BIAF has additional filings available on the SEC site.

Restatement Radar

6 numbers bioAffinity Technologies, Inc. later changed — same XBRL tag, both filings linked.

Operating Expenses·Q3 2023
Notable restatement
$2.6M▲ 3.0%
was$2.5M
Revised up in a 10-Q.
No amendment filed
As reported · Nov 14, 2023 10-Q · Nov 14, 2024us-gaap:OperatingExpenses
Interest Paid, Excluding Capitalized Interest, Operating Activities·Q1 2023
Major restatement
$11.8K▲ 614.1%
was$1.7K
Revised up in a 10-Q.
No amendment filed
As reported · May 15, 2023 10-Q · May 15, 2024us-gaap:InterestPaidNet
Share-based Payment Arrangement, Expense·FY 2022
Major restatement
$248.6K▼ 99.9%
was$248.6M
Revised down in a 10-K.
No amendment filed
As reported · Mar 31, 2023 10-K · Apr 1, 2024us-gaap:AllocatedShareBasedCompensationExpense
Common Stock, Value, Issued·As of Dec 31, 2024
Major restatement
$3.6K▼ 96.7%
was$106.6K
Revised down in a 10-K.
No amendment filed
As reported · Mar 31, 2025 10-K · Mar 16, 2026us-gaap:CommonStockValue
Depreciation·Q3 2023
Major restatement
$45.1K▲ 91.9%
was$23.5K
Revised up in a 10-Q.
No amendment filed
As reported · Nov 14, 2023 10-Q · Nov 14, 2024us-gaap:Depreciation
Lease, Cost·Q2 2024
Major restatement
$276.7K▲ 86.5%
was$148.4K
Revised up in a 10-Q.
No amendment filed
As reported · Aug 14, 2024 10-Q · Aug 14, 2025us-gaap:LeaseCost

BIAF is not the only one.

See every restatement we've found across the market — or get an alert the next time BIAF revises a number.

Restatement Radar Alert me

Restatements are detected by comparing every vintage of a fact across all of bioAffinity Technologies, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows BIAF's most significant revisions, and a figure absent from it has not been certified as unrevised.

Smart Money
Institutional

Who is buying and selling bioAffinity Technologies, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.

Unlock with InstitutionalIncluded in the $499/mo plan — full universe, back to 1993.

Illustrative structure — live values unlock with a token

Form 4Insider transactions — officers & directors
13FInstitutional holdings — who owns it, quarter over quarter
13D/GBlockholders & activist stakes

Research Reports

No published research on BIAF yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BIAF and publish the result to your public profile.

Browse the research catalog Generate one with your agent

Ask about bioAffinity Technologies, Inc.

Continue in Workspace — cited answers on BIAF, a thesis you can score, or a signal on the next filing.

Open in Workspace

Get 15 years of data

Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.

View plans

Query via Python SDK

Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.

SDK docs

Connect via MCP Server

Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.